Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05936749
Other study ID # 14/23
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 2, 2016
Est. completion date December 12, 2022

Study information

Verified date June 2023
Source Istituto Clinico Humanitas
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This monocentric retrospective observational study aims to evaluate the efficacy of pre-implantation genetic testing for monogenic diseases (PGT-M). The effectiveness will be assessed in terms of live birth rate (LBR), cumulative live birth rate (CLBR) per couple, and abortion rate (AR). Considering how many cycles the participants have undergone to achieve a viable blastocyst. The secondary objective is to evaluate the incidence of aneuploidy in unaffected embryos, in order to understand the need for pre-implantation genetic testing for aneuploidy (PGT-A)in addition to PGT-M.


Recruitment information / eligibility

Status Completed
Enrollment 76
Est. completion date December 12, 2022
Est. primary completion date December 12, 2022
Accepts healthy volunteers
Gender Female
Age group 34 Years to 42 Years
Eligibility Inclusion Criteria: - Patients fertile or infertile that have undergone preimplantation genetic testing for monogenic diseases (PGTM). Exclusion Criteria: - No exclusion criteria will be taken into consideration.

Study Design


Related Conditions & MeSH terms


Intervention

Genetic:
Pre-implantation genetic testing


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Istituto Clinico Humanitas

Outcome

Type Measure Description Time frame Safety issue
Primary Live birth rate (LBR) LBR will be measured as a percentage 7 years of inclusion
Primary Cumulative live birth rate (CLBR) per couple CLBR per couple will be measured as a percentage 7 years of inclusion
Primary Abortion rate (AR) AR will be measured as a percentage 7 years of inclusion
Secondary Aneuploidy Aneuploidy embryo rate will be measured as a percentage 7 years of inclusion
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03548779 - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 N/A
Completed NCT03292302 - Phase 1 Study of ELX-02 in Healthy Adults Phase 1
Withdrawn NCT03658382 - Virtual Visits for Results Disclosure N/A
Recruiting NCT02266615 - Biobank Clinical Genetics Maastricht (KG01)
Recruiting NCT02450851 - Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
Recruiting NCT05472714 - Educational Video for Genetic Testing N/A
Recruiting NCT04285814 - Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood
Completed NCT05443113 - Young Pectus Excavatum Patients and Genetic Defects
Completed NCT05655741 - Modified Delphi for Genomic Bereavement Care
Completed NCT03847909 - A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 Phase 2
Completed NCT04584528 - Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease N/A
Not yet recruiting NCT06048523 - Prospective Cohort Study of Neurogenetic Diseases N/A
Completed NCT02225522 - Genomic Sequencing in Acutely Ill Neonates N/A
Enrolling by invitation NCT06089954 - Penn Medicine Biobank Return of Results Program N/A
Completed NCT03713333 - Implementing Digital Health in a Learning Health System N/A
Completed NCT03309605 - Phase 1 Study of ELX-02 in Healthy Adult Subjects Phase 1
Recruiting NCT05499091 - Functional Study to Indentify Genetic Etiology of Rare Diseases - ORIGIN N/A
Completed NCT04556500 - Turkish Version of the Affordance in the Home Environment for Motor Development-Toddler (AHEMD-T)
Completed NCT04556487 - Turkish Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS)
Recruiting NCT02551081 - Genomic Sequencing and Personalized Treatment for Birth Defects in Neonatal Intensive Care Units